US Stock MarketDetailed Quotes

GSK GlaxoSmithKline

Watchlist
  • 34.170
  • -0.280-0.81%
Close Dec 12 16:00 ET
  • 34.020
  • -0.150-0.44%
Pre 08:07 ET
69.72BMarket Cap22.22P/E (TTM)

GlaxoSmithKline Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
-1.66%8.01B
9.84%7.88B
5.93%7.36B
3.42%30.33B
9.16%8.05B
4.06%8.15B
3.59%7.18B
-3.32%6.95B
18.74%29.32B
4.24%7.38B
Operating revenue
-1.66%8.01B
9.84%7.88B
5.93%7.36B
3.42%30.33B
9.16%8.05B
4.06%8.15B
3.59%7.18B
-3.32%6.95B
18.74%29.32B
4.24%7.38B
Cost of revenue
5.50%2.4B
9.83%2.12B
1.39%1.97B
-10.35%8.57B
8.04%2.42B
-6.23%2.27B
-11.21%1.93B
-28.49%1.94B
17.04%9.55B
-19.64%2.24B
Gross profit
-4.43%5.62B
9.84%5.76B
7.69%5.39B
10.08%21.76B
9.65%5.63B
8.68%5.88B
10.37%5.25B
11.96%5.01B
19.58%19.77B
19.74%5.14B
Operating expense
38.21%5.43B
32.56%4.12B
33.39%3.9B
10.56%14.42B
50.00%4.46B
-6.86%3.93B
-15.44%3.11B
34.22%2.93B
11.89%13.04B
-9.27%2.97B
Selling and administrative expenses
65.51%3.8B
8.69%2.47B
-2.61%2.09B
12.10%9.39B
9.84%2.68B
11.67%2.3B
9.78%2.27B
18.27%2.14B
18.42%8.37B
11.17%2.44B
-General and administrative expense
65.51%3.8B
8.69%2.47B
-2.61%2.09B
12.10%9.39B
9.84%2.68B
11.67%2.3B
9.78%2.27B
18.27%2.14B
18.42%8.37B
11.17%2.44B
Research and development costs
-7.37%1.46B
10.14%1.48B
13.81%1.43B
13.39%6.22B
13.91%2.05B
17.01%1.58B
7.97%1.34B
14.23%1.26B
9.34%5.49B
30.60%1.8B
Other operating expenses
-8.72%335M
--318M
--533M
----
----
-65.64%367M
----
----
----
----
Operating profit
-90.30%189M
-23.12%1.65B
-28.43%1.49B
9.15%7.35B
-45.79%1.17B
63.64%1.95B
98.06%2.14B
-9.20%2.08B
37.95%6.73B
113.62%2.16B
Net non-operating interest income expense
21.52%-124M
1.32%-150M
22.99%-134M
11.02%-735M
5.99%-251M
11.24%-158M
16.94%-152M
12.12%-174M
-9.40%-826M
-42.78%-267M
Non-operating interest income
33.33%32M
-27.27%24M
10.34%32M
54.84%48M
-100.00%-38M
9.09%24M
57.14%33M
314.29%29M
181.82%31M
-533.33%-19M
Non-operating interest expense
-14.29%156M
-5.95%174M
-18.23%166M
-12.23%725M
-28.57%155M
-9.00%182M
-9.31%185M
-0.98%203M
8.12%826M
19.23%217M
Total other finance cost
----
----
----
87.10%58M
----
----
----
----
1,450.00%31M
----
Other net income (expense)
Special income (charges)
--0
--0
--0
42.81%-704M
42.73%-705M
--0
--0
--1M
-5,452.17%-1.23B
-2,186.44%-1.23B
-Less：Restructuring and merger&acquisition
----
----
----
-50.78%791M
----
----
----
----
51.89%1.61B
----
-Less:Other special charges
----
----
----
76.86%-87M
---86M
----
----
---1M
65.22%-376M
----
Income before tax
-96.43%64M
-24.76%1.5B
-28.95%1.36B
7.75%6.06B
-76.69%379M
76.98%1.79B
121.76%1.99B
-8.93%1.91B
56.38%5.63B
436.63%1.63B
Income tax
-100.39%-1M
-21.07%191M
-0.72%274M
6.93%756M
-2,000.00%-19M
10.30%257M
61.33%242M
-14.55%276M
751.81%707M
100.85%1M
Net income
-95.76%65M
-25.27%1.3B
-33.72%1.08B
-66.02%5.31B
-75.43%398M
-85.87%1.53B
78.97%1.75B
-24.73%1.63B
206.53%15.62B
74.19%1.62B
Net income continuous Operations
-95.76%65M
-25.27%1.3B
-33.72%1.08B
7.86%5.31B
-75.51%398M
96.92%1.53B
133.91%1.75B
-7.91%1.63B
39.96%4.92B
286.90%1.63B
Net income discontinuous operations
----
----
----
--0
----
----
----
----
577.22%10.7B
-100.98%-5M
Minority interest income
75.71%123M
8.26%131M
-75.18%35M
-42.86%380M
-61.60%48M
84.21%70M
-11.68%121M
-61.37%141M
-6.47%665M
125M
Net income attributable to the parent company
-103.96%-58M
-27.77%1.17B
-29.80%1.05B
-67.05%4.93B
-76.59%350M
-86.47%1.46B
93.79%1.62B
-17.31%1.49B
241.07%14.96B
582.65%1.5B
Preferred stock dividends
Other preferred stock dividends
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
-103.96%-58M
-27.77%1.17B
-29.80%1.05B
-67.05%4.93B
-76.59%350M
-86.47%1.46B
93.79%1.62B
-17.31%1.49B
241.07%14.96B
582.65%1.5B
Basic earnings per share
-103.88%-0.028
-28.18%0.576
-30.16%0.514
-67.26%2.432
-76.82%0.172
-86.55%0.722
140.99%0.802
-18.04%0.736
238.87%7.428
97.87%0.742
Diluted earnings per share
-103.93%-0.028
-28.21%0.57
-30.41%0.508
-67.26%2.398
-76.71%0.17
-86.55%0.712
140.90%0.794
-17.79%0.73
238.45%7.324
98.64%0.73
Dividend per share
8.69%0.2938
3.82%0.3019
12.82%0.3198
-25.33%1.1253
0.16%0.2807
-14.72%0.2703
-15.84%0.2908
-49.75%0.2835
-24.31%1.507
-42.24%0.2803
Currency Unit
GBP
GBP
GBP
GBP
GBP
GBP
GBP
GBP
GBP
GBP
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue -1.66%8.01B9.84%7.88B5.93%7.36B3.42%30.33B9.16%8.05B4.06%8.15B3.59%7.18B-3.32%6.95B18.74%29.32B4.24%7.38B
Operating revenue -1.66%8.01B9.84%7.88B5.93%7.36B3.42%30.33B9.16%8.05B4.06%8.15B3.59%7.18B-3.32%6.95B18.74%29.32B4.24%7.38B
Cost of revenue 5.50%2.4B9.83%2.12B1.39%1.97B-10.35%8.57B8.04%2.42B-6.23%2.27B-11.21%1.93B-28.49%1.94B17.04%9.55B-19.64%2.24B
Gross profit -4.43%5.62B9.84%5.76B7.69%5.39B10.08%21.76B9.65%5.63B8.68%5.88B10.37%5.25B11.96%5.01B19.58%19.77B19.74%5.14B
Operating expense 38.21%5.43B32.56%4.12B33.39%3.9B10.56%14.42B50.00%4.46B-6.86%3.93B-15.44%3.11B34.22%2.93B11.89%13.04B-9.27%2.97B
Selling and administrative expenses 65.51%3.8B8.69%2.47B-2.61%2.09B12.10%9.39B9.84%2.68B11.67%2.3B9.78%2.27B18.27%2.14B18.42%8.37B11.17%2.44B
-General and administrative expense 65.51%3.8B8.69%2.47B-2.61%2.09B12.10%9.39B9.84%2.68B11.67%2.3B9.78%2.27B18.27%2.14B18.42%8.37B11.17%2.44B
Research and development costs -7.37%1.46B10.14%1.48B13.81%1.43B13.39%6.22B13.91%2.05B17.01%1.58B7.97%1.34B14.23%1.26B9.34%5.49B30.60%1.8B
Other operating expenses -8.72%335M--318M--533M---------65.64%367M----------------
Operating profit -90.30%189M-23.12%1.65B-28.43%1.49B9.15%7.35B-45.79%1.17B63.64%1.95B98.06%2.14B-9.20%2.08B37.95%6.73B113.62%2.16B
Net non-operating interest income expense 21.52%-124M1.32%-150M22.99%-134M11.02%-735M5.99%-251M11.24%-158M16.94%-152M12.12%-174M-9.40%-826M-42.78%-267M
Non-operating interest income 33.33%32M-27.27%24M10.34%32M54.84%48M-100.00%-38M9.09%24M57.14%33M314.29%29M181.82%31M-533.33%-19M
Non-operating interest expense -14.29%156M-5.95%174M-18.23%166M-12.23%725M-28.57%155M-9.00%182M-9.31%185M-0.98%203M8.12%826M19.23%217M
Total other finance cost ------------87.10%58M----------------1,450.00%31M----
Other net income (expense)
Special income (charges) --0--0--042.81%-704M42.73%-705M--0--0--1M-5,452.17%-1.23B-2,186.44%-1.23B
-Less：Restructuring and merger&acquisition -------------50.78%791M----------------51.89%1.61B----
-Less:Other special charges ------------76.86%-87M---86M-----------1M65.22%-376M----
Income before tax -96.43%64M-24.76%1.5B-28.95%1.36B7.75%6.06B-76.69%379M76.98%1.79B121.76%1.99B-8.93%1.91B56.38%5.63B436.63%1.63B
Income tax -100.39%-1M-21.07%191M-0.72%274M6.93%756M-2,000.00%-19M10.30%257M61.33%242M-14.55%276M751.81%707M100.85%1M
Net income -95.76%65M-25.27%1.3B-33.72%1.08B-66.02%5.31B-75.43%398M-85.87%1.53B78.97%1.75B-24.73%1.63B206.53%15.62B74.19%1.62B
Net income continuous Operations -95.76%65M-25.27%1.3B-33.72%1.08B7.86%5.31B-75.51%398M96.92%1.53B133.91%1.75B-7.91%1.63B39.96%4.92B286.90%1.63B
Net income discontinuous operations --------------0----------------577.22%10.7B-100.98%-5M
Minority interest income 75.71%123M8.26%131M-75.18%35M-42.86%380M-61.60%48M84.21%70M-11.68%121M-61.37%141M-6.47%665M125M
Net income attributable to the parent company -103.96%-58M-27.77%1.17B-29.80%1.05B-67.05%4.93B-76.59%350M-86.47%1.46B93.79%1.62B-17.31%1.49B241.07%14.96B582.65%1.5B
Preferred stock dividends
Other preferred stock dividends 0000000000
Net income attributable to common stockholders -103.96%-58M-27.77%1.17B-29.80%1.05B-67.05%4.93B-76.59%350M-86.47%1.46B93.79%1.62B-17.31%1.49B241.07%14.96B582.65%1.5B
Basic earnings per share -103.88%-0.028-28.18%0.576-30.16%0.514-67.26%2.432-76.82%0.172-86.55%0.722140.99%0.802-18.04%0.736238.87%7.42897.87%0.742
Diluted earnings per share -103.93%-0.028-28.21%0.57-30.41%0.508-67.26%2.398-76.71%0.17-86.55%0.712140.90%0.794-17.79%0.73238.45%7.32498.64%0.73
Dividend per share 8.69%0.29383.82%0.301912.82%0.3198-25.33%1.12530.16%0.2807-14.72%0.2703-15.84%0.2908-49.75%0.2835-24.31%1.507-42.24%0.2803
Currency Unit GBPGBPGBPGBPGBPGBPGBPGBPGBPGBP
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Salesforce
CRM
+0.90%
Apple
AAPL
+0.60%
Cisco
CSCO
+0.44%
Advanced Micro Devices
AMD
+0.35%
Alibaba
BABA
+0.28%

Unlock the Full List

Investment Theme CAR-T Therapy
CAR-T Therapy
Intraday-0.18%
Infectious Disease
Infectious Disease
Intraday-0.55%